| Title |
Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
|
|---|---|
| Published in |
Patient related outcome measures, December 2017
|
| DOI | 10.2147/prom.s122401 |
| Pubmed ID | |
| Authors |
Charlotte Druart, Souraya El Sankari, Vincent van Pesch |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 65 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 14% |
| Student > Ph. D. Student | 8 | 12% |
| Researcher | 8 | 12% |
| Student > Master | 5 | 8% |
| Student > Postgraduate | 4 | 6% |
| Other | 10 | 15% |
| Unknown | 21 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 25% |
| Neuroscience | 9 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 12% |
| Nursing and Health Professions | 2 | 3% |
| Business, Management and Accounting | 1 | 2% |
| Other | 6 | 9% |
| Unknown | 23 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2018.
All research outputs
#15,528,733
of 26,017,215 outputs
Outputs from Patient related outcome measures
#76
of 196 outputs
Outputs of similar age
#234,826
of 451,438 outputs
Outputs of similar age from Patient related outcome measures
#5
of 9 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 196 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,438 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.